JANUARY 21, 2026 AT 11:20 AM
Johnson & Johnson (JNJ) Q4 2025 (USD): Adj. EPS 2.46 (exp. 2.49), Revenue 24.6bln (exp. 24.15bln); guides initial FY26 Adj. EPS 11.53 (exp. 11.46), Revenue 100.5bln (exp. 98.5bln)
Importance
Level 1
- EPS growth skewed to H2 over H1 in 2026.